Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection.

Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection.

Bibliografiset tiedot
Päätekijät:	Yegnasew Takele, Tamrat Abebe, Teklu Weldegebreal, Asrat Hailu, Workagegnehu Hailu, Zewdu Hurissa, Jemal Ali, Ermiyas Diro, Yifru Sisay, Tom Cloke, Manuel Modolell, Markus Munder, Fabienne Tacchini-Cottier, Ingrid Müller, Pascale Kropf
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Public Library of Science (PLoS) 2013-01-01
Sarja:	PLoS Neglected Tropical Diseases
Linkit:	http://europepmc.org/articles/PMC3580194

Samankaltaisia teoksia

Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia.
Tekijä: Tamrat Abebe, et al.
Julkaistu: (2013-01-01)

Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia.
Tekijä: Tamrat Abebe, et al.
Julkaistu: (2012-01-01)

Age-related alteration of arginase activity impacts on severity of leishmaniasis.
Tekijä: Ingrid Müller, et al.
Julkaistu: (2008-05-01)

Inference of population structure of Leishmania donovani strains isolated from different Ethiopian visceral leishmaniasis endemic areas.
Tekijä: Tesfaye Gelanew, et al.
Julkaistu: (2010-01-01)

Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.
Tekijä: Manuel Modolell, et al.
Julkaistu: (2009-07-01)

Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production.
Tekijä: Emebet Adem, et al.
Julkaistu: (2016-03-01)

Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites.
Tekijä: Fitsumbrhan Tajebe, et al.
Julkaistu: (2017-07-01)

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
Tekijä: Eltahir A G Khalil, et al.
Julkaistu: (2014-01-01)

Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages
Tekijä: Meera eRath, et al.
Julkaistu: (2014-10-01)

Phenotypic alteration of neutrophils in the blood of HIV seropositive patients.
Tekijä: Tom Cloke, et al.
Julkaistu: (2013-01-01)

Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study.
Tekijä: Ermias Diro, et al.
Julkaistu: (2015-05-01)

Visceral leishmaniasis patients display altered composition and maturity of neutrophils as well as impaired neutrophil effector functions
Tekijä: Endalew Yizengaw, et al.
Julkaistu: (2016-11-01)

Malnutrition in Healthy Individuals Results in Increased Mixed Cytokine Profiles, Altered Neutrophil Subsets and Function.
Tekijä: Y Takele, et al.
Julkaistu: (2016-01-01)

The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection
Tekijä: Katiuska Passelli, et al.
Julkaistu: (2021-03-01)

Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia.
Tekijä: Anne Mehl, et al.
Julkaistu: (2014-01-01)

Shigella Bacteremia in a Patient with Visceral Leishmaniasis
Tekijä: Mengistu Endris, et al.
Julkaistu: (2013-01-01)

Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.
Tekijä: Workagegnehu Hailu, et al.
Julkaistu: (2021-01-01)

Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection.
Tekijä: Thomas Cloke, et al.
Julkaistu: (2012-01-01)

A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear.
Tekijä: Steffen eSchuster, et al.
Julkaistu: (2014-05-01)

Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
Tekijä: Ahmed Musa, et al.
Julkaistu: (2012-01-01)

Prevalence of orthostatic hypotension and associated factors among older people with hypertension in Northern Ethiopia
Tekijä: Workagegnehu Hailu, et al.
Julkaistu: (2024-11-01)

Characteristics of bacterial sepsis among patients with visceral leishmaniasis
Tekijä: Mengistu Endris, et al.
Julkaistu: (2014-11-01)

Following successful anti-leishmanial treatment, neutrophil counts, CD10 expression and phagocytic capacity remain reduced in visceral leishmaniasis patients co-infected with HIV.
Tekijä: Yegnasew Takele, et al.
Julkaistu: (2022-08-01)

Does T helper differentiation correlate with resistance or susceptibility to infection with L. major? Some answers from the murine model
Tekijä: Fabienne eTacchini-Cottier, et al.
Julkaistu: (2012-02-01)

Cutaneous leishmaniasis in Kutaber District, Ethiopia: Prevalence, sand fly fauna and community knowledge, attitude and practices
Tekijä: Abib Berhanu, et al.
Julkaistu: (2023-08-01)

Visceral Leishmaniasis and HIV coinfection in East Africa.
Tekijä: Ermias Diro, et al.
Julkaistu: (2014-06-01)

High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
Tekijä: Ermias Diro, et al.
Julkaistu: (2014-05-01)

Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes
Tekijä: Verena Vonwirth, et al.
Julkaistu: (2021-02-01)

Multitracer Stable Isotope Quantification of Arginase and Nitric Oxide Synthase Activity in a Mouse Model of Pseudomonas Lung Infection
Tekijä: Hartmut Grasemann, et al.
Julkaistu: (2014-01-01)

Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis.
Tekijä: Emebet Adem, et al.
Julkaistu: (2024-08-01)

Endometrial tuberculosis among patients undergoing endometrial biopsy at Tikur Anbesa specialized hospital, Addis Ababa, Ethiopia
Tekijä: Sileshi Abdissa, et al.
Julkaistu: (2018-07-01)

Patients' experience of undergoing maintenance hemodialysis. An interview study from Ethiopia.
Tekijä: Mignote Hailu Gebrie, et al.
Julkaistu: (2023-01-01)

Health-related quality of life among patients with end-stage renal disease undergoing hemodialysis in Ethiopia: a cross-sectional survey
Tekijä: Mignote Hailu Gebrie, et al.
Julkaistu: (2023-04-01)

Survival Mechanisms Used by Some Leishmania Species to Escape Neutrophil Killing
Tekijä: Ivo B. Regli, et al.
Julkaistu: (2017-11-01)

Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study
Tekijä: Abdene Weya Kaso, et al.
Julkaistu: (2022-01-01)

Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.
Tekijä: Abdene Weya Kaso, et al.
Julkaistu: (2022-01-01)

Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
Tekijä: Asrat Hailu, et al.
Julkaistu: (2010-10-01)

Editorial: The Skin Immune Response to Infectious Agents
Tekijä: Fatima Conceição-Silva, et al.
Julkaistu: (2022-01-01)

Synthesis of Arginase Inhibitors: An Overview
Tekijä: Maria Cristina Molaro, et al.
Julkaistu: (2025-01-01)

Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
Tekijä: Philippe O Gannon, et al.
Julkaistu: (2010-08-01)